Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 93 publications
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Trial of AWZ1066S, an Anti-Wolbachia Candidate Macrofilaricide.
Journal: Clinical pharmacology in drug development
Published: March 15, 2024
Diverse RNA viruses of parasitic nematodes can elicit antibody responses in vertebrate hosts.
Journal: Nature microbiology
Published: August 15, 2023
Design, synthesis and modelling of photoreactive chemical probes for investigating target engagement of plasmepsin IX and X in Plasmodium falciparum.
Journal: RSC chemical biology
Published: June 29, 2023
Dirofilariasis mouse models for heartworm preclinical research.
Journal: Frontiers in microbiology
Published: April 18, 2023
Targeting the Ubiquinol-Reduction (Qi) Site of the Mitochondrial Cytochrome bc1 Complex for the Development of Next Generation Quinolone Antimalarials.
Journal: Biology
Published: May 18, 2022
Wolbachia depletion blocks transmission of lymphatic filariasis by preventing chitinase-dependent parasite exsheathment.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 04, 2022
Remdesivir-ivermectin combination displays synergistic interaction with improved in vitro activity against SARS-CoV-2.
Journal: International journal of antimicrobial agents
Published: September 09, 2021
Development of Pyrazolopyrimidine Anti-Wolbachia Agents for the Treatment of Filariasis.
Journal: ACS medicinal chemistry letters
Published: April 15, 2021
Enantioselective Synthesis and Profiling of Potent, Nonlinear Analogues of Antimalarial Tetraoxanes E209 and N205.
Journal: ACS medicinal chemistry letters
Published: January 18, 2021
Therapeutic Potential of Nitazoxanide: An Appropriate Choice for Repurposing versus SARS-CoV-2?
Journal: ACS infectious diseases
Published: December 22, 2020
Last Updated: 09/26/2026